Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease

Valerio Nobili, Anna Alisi, Giuliano Torre, Rita De Vito, Andrea Pietrobattista, Giuseppe Morino, Jean De Ville De Goyet, Giorgio Bedogni, Massimo Pinzani

Research output: Contribution to journalArticle

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in children and adolescents, and it may progress to liver fibrosis and cirrhosis. Liver biopsy, which is the recognized gold standard for the diagnosis of hepatic fibrosis, is invasive. Thus, there has been increasing interest in the development of noninvasive markers. Hyaluronic acid (HA) has been shown to be a good marker of liver fibrosis in adults. In the current study, we evaluated the association of HA with liver fibrosis in 100 consecutive children with biopsy-proven NAFLD. In all, 65% of the children had liver fibrosis. Using proportional-odds ordinal logistic regression, we found that values of HA ≥ 1200 ng/mL made the absence of fibrosis (F0) unlikely (7%, 95% confidence interval [CI]: 1% to 14%), whereas values of HA ≥ 2100 ng/mL made F2, F3, or F4 fibrosis likely (89%, 95% CI: 75% to 100%). Our study shows that HA is a predictor of fibrosis in children with NAFLD followed at a tertiary care center. Additional studies are needed to test whether HA can be employed to predict liver fibrosis in pediatric populations with similar and lower prevalence of liver fibrosis.

Original languageEnglish
Pages (from-to)229-234
Number of pages6
JournalTranslational Research
Volume156
Issue number4
DOIs
Publication statusPublished - 2010

Fingerprint

Hyaluronic Acid
Liver Cirrhosis
Liver
Fibrosis
Biopsy
Confidence Intervals
Non-alcoholic Fatty Liver Disease
Tertiary Care Centers
Liver Diseases
Chronic Disease
Pediatrics
Logistic Models
Logistics
Population

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, medical
  • Public Health, Environmental and Occupational Health

Cite this

Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease. / Nobili, Valerio; Alisi, Anna; Torre, Giuliano; De Vito, Rita; Pietrobattista, Andrea; Morino, Giuseppe; De Ville De Goyet, Jean; Bedogni, Giorgio; Pinzani, Massimo.

In: Translational Research, Vol. 156, No. 4, 2010, p. 229-234.

Research output: Contribution to journalArticle

@article{7c8932689adf42048f71f6f801ebb6f4,
title = "Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease",
abstract = "Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in children and adolescents, and it may progress to liver fibrosis and cirrhosis. Liver biopsy, which is the recognized gold standard for the diagnosis of hepatic fibrosis, is invasive. Thus, there has been increasing interest in the development of noninvasive markers. Hyaluronic acid (HA) has been shown to be a good marker of liver fibrosis in adults. In the current study, we evaluated the association of HA with liver fibrosis in 100 consecutive children with biopsy-proven NAFLD. In all, 65{\%} of the children had liver fibrosis. Using proportional-odds ordinal logistic regression, we found that values of HA ≥ 1200 ng/mL made the absence of fibrosis (F0) unlikely (7{\%}, 95{\%} confidence interval [CI]: 1{\%} to 14{\%}), whereas values of HA ≥ 2100 ng/mL made F2, F3, or F4 fibrosis likely (89{\%}, 95{\%} CI: 75{\%} to 100{\%}). Our study shows that HA is a predictor of fibrosis in children with NAFLD followed at a tertiary care center. Additional studies are needed to test whether HA can be employed to predict liver fibrosis in pediatric populations with similar and lower prevalence of liver fibrosis.",
author = "Valerio Nobili and Anna Alisi and Giuliano Torre and {De Vito}, Rita and Andrea Pietrobattista and Giuseppe Morino and {De Ville De Goyet}, Jean and Giorgio Bedogni and Massimo Pinzani",
year = "2010",
doi = "10.1016/j.trsl.2010.05.008",
language = "English",
volume = "156",
pages = "229--234",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease

AU - Nobili, Valerio

AU - Alisi, Anna

AU - Torre, Giuliano

AU - De Vito, Rita

AU - Pietrobattista, Andrea

AU - Morino, Giuseppe

AU - De Ville De Goyet, Jean

AU - Bedogni, Giorgio

AU - Pinzani, Massimo

PY - 2010

Y1 - 2010

N2 - Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in children and adolescents, and it may progress to liver fibrosis and cirrhosis. Liver biopsy, which is the recognized gold standard for the diagnosis of hepatic fibrosis, is invasive. Thus, there has been increasing interest in the development of noninvasive markers. Hyaluronic acid (HA) has been shown to be a good marker of liver fibrosis in adults. In the current study, we evaluated the association of HA with liver fibrosis in 100 consecutive children with biopsy-proven NAFLD. In all, 65% of the children had liver fibrosis. Using proportional-odds ordinal logistic regression, we found that values of HA ≥ 1200 ng/mL made the absence of fibrosis (F0) unlikely (7%, 95% confidence interval [CI]: 1% to 14%), whereas values of HA ≥ 2100 ng/mL made F2, F3, or F4 fibrosis likely (89%, 95% CI: 75% to 100%). Our study shows that HA is a predictor of fibrosis in children with NAFLD followed at a tertiary care center. Additional studies are needed to test whether HA can be employed to predict liver fibrosis in pediatric populations with similar and lower prevalence of liver fibrosis.

AB - Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in children and adolescents, and it may progress to liver fibrosis and cirrhosis. Liver biopsy, which is the recognized gold standard for the diagnosis of hepatic fibrosis, is invasive. Thus, there has been increasing interest in the development of noninvasive markers. Hyaluronic acid (HA) has been shown to be a good marker of liver fibrosis in adults. In the current study, we evaluated the association of HA with liver fibrosis in 100 consecutive children with biopsy-proven NAFLD. In all, 65% of the children had liver fibrosis. Using proportional-odds ordinal logistic regression, we found that values of HA ≥ 1200 ng/mL made the absence of fibrosis (F0) unlikely (7%, 95% confidence interval [CI]: 1% to 14%), whereas values of HA ≥ 2100 ng/mL made F2, F3, or F4 fibrosis likely (89%, 95% CI: 75% to 100%). Our study shows that HA is a predictor of fibrosis in children with NAFLD followed at a tertiary care center. Additional studies are needed to test whether HA can be employed to predict liver fibrosis in pediatric populations with similar and lower prevalence of liver fibrosis.

UR - http://www.scopus.com/inward/record.url?scp=77957309026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957309026&partnerID=8YFLogxK

U2 - 10.1016/j.trsl.2010.05.008

DO - 10.1016/j.trsl.2010.05.008

M3 - Article

C2 - 20875899

AN - SCOPUS:77957309026

VL - 156

SP - 229

EP - 234

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 4

ER -